CEO Richard Clark

Feb 15 (Reuters) - Merck & Co plans to form a joint venture with two Brazilian pharmaceutical companies to sell medicines in Brazil, the U.S. drugmaker said on Wednesday. The joint venture, which will initially include about 30 products, is the ...  

WHITEHOUSE STATION, N.J., Feb 13, 2012 (BUSINESS WIRE) -- Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved ZIOPTAN(TM) (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution. ZIOPTAN (pronounced zye-OP-tan) is approved for reducing elevated intraocular pressure...  

Diane P. Sullivan, the Princeton, N.J.-based litigator who secured a 2005 victory for client Merck in the Vioxx products liability lawsuit, has left Dechert for New York mega-firm Weil Gotshal & Manges. Joining Sullivan in the move is partner Kathleen O’Connor, the former in-house Merck lawyer who ultimately joined Dechert and worked on the Vioxx case. Sullivan, who joined Dechert in 2001 from Lowenstein Sandler, specializes in litigating...  

Kevin Grogan The unpaid debts of European healthcare systems owed to pharmaceutical companies reportedly stands at about 12 billion euros, and half of that is a result of Spain having problems in paying its bills. The problem was addressed by Bruno Strigini, president of Europe/Canada at Merck & Co at The Economist's Pharma Summit summit in London last week. He said that 6 billion euros is outstanding in Spain and a further 4...  

Global pharma major Merck, which formed a joint venture with Sun Pharma, said that it was open for more alliances/ partnerships with other Indian companies as part of the growth strategy for emerging markets and launch innovative new products. Cardiovascular diseases, diabetes, viral diseases, anti-infectives, and dermatology are among the areas in which Merck & Co, known as MSD in India and markets...